COPD trials recruiting in New York

All COPD trials nationally

Cities in New York

Recruiting trials in New York

• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · New York: Albany, Bronxville, Brooklyn, Massapequa
• A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
  NCT06944925 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · New York: New York
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
  NCT07082738 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · New York: Mount Kisco
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
  NCT06883305 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · New York: Buffalo, Cortland, Horseheads, Massapequa
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
  NCT06878261 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · New York: Staten Island, Syracuse, The Bronx
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
  NCT07363694 · Phase: Phase 2, Phase 3 · Ages: 35 Years to 80 Years · Sex: All (male and female) · New York: Chappaqua, Flushing, Mount Kisco
• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
  NCT07059091 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · New York: New York
• Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
  NCT06122077 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · New York: Binghamton
• Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
  NCT07222410 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · New York: New York
• Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
  NCT01776398 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
  NCT06634810 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · New York: New York
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
  NCT06961214 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · New York: Mount Kisco, New Windsor
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
  NCT07190209 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · New York: Flushing
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
  NCT07190222 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · New York: New Windsor
• Evaluation Of The Lung Microbiome In NTM Bronchiectasis
  NCT02779478 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Lung Microbiome and Inflammation in Early COPD
  NCT02777879 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: New York
• PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
  NCT05306743 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• PiMZ Longitudinal Cohort (PiMZ Logic)
  NCT06505603 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• SPIROMICS Study of Early COPD Progression (SOURCE)
  NCT05033990 · Phase: Not specified · Ages: 30 Years to 55 Years · Sex: All (male and female) · New York: New York
• Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
  NCT07512687 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · New York: Buffalo
• Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
  NCT07610395 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · New York: Binghamton, Brooklyn